Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080301
Status:
COMPLETED
Last Update Posted:
2020-11-02
First Post:
2004-03-26
Brief Title:
Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Sponsor:
R-Pharm
Organization:
R-Pharm
Organization Data
Organization:
R-Pharm
Class:
INDUSTRY
Study ID:
CA163-046
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
R-Pharm
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Study Director
Old Organization:
Bristol-Myers Squibb